Home / Pharmaceutical company intelligence
Pharmaceutical company intelligence

Focus & Rulz Pharmaceuticals (Pvt) Ltd

Private pharmaceutical manufacturer · Islamabad · Pakistan

Islamabad-based pharmaceutical manufacturer established in 2004 with domestic, export and toll-manufacturing operations.

Sourced corporate profile Corporate identity fields are source-tracked; portfolio, price and competitor intelligence remains independently calculated by MedInfoBase.
Official website ↗ Official contact ↗
ShareSend this page
Evidence & freshness

What is sourced, and how recent is it?

Public-source corporate details
Latest regulatory-source observation23 Sep 2026Newest linked source record observed by MedInfoBase
Latest portfolio source check22 Sep 2026Latest source-check date across this published portfolio
Latest effective price date17 Aug 2026Newest effective date among published current price records
Corporate profile evidence4 sourcesCorporate source details checked 16 Aug 2026

Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.

Regulatory & corporate identity

Company profile

Public-source corporate details
Legal / official name
Focus & Rulz Pharmaceuticals (Pvt.) Ltd.
Company type
Private pharmaceutical manufacturer
Address
44 Industrial Triangle, Kahuta Road, Islamabad 44000, Pakistan · 44000
Phone
+92 51 4493174
Official contact
Contact page ↗
Corporate source details checked
16 Aug 2026
Corporate profile completeness
88%
DRAP manufacturing licenceAs published by the DRAP Licensing Division. DRAP issues this list for stakeholder review and states it is not a reference for litigation, claims or citation.
Formulation 000628 Focus & Rulz Pharmaceuticals (Pvt) Ltd. · Islamabad
Source-linked licence identifiersShown as recorded in linked source rows; not a claim of current validity.
DML 000628 102 linked products · source seen 23 Sep 2026 View source ↗
Corporate profile source ledger Contact Page Url source ↗ Logo Source Url source ↗ Profile Source Url source ↗
Location intelligence

Company location

Google Maps
Location recorded

A sourced company location is recorded. Use the map link below for directions.

Open in Google Maps ↗
Intelligence snapshot

Portfolio at a glance

Not sales data · published MedInfoBase database view
Rx102public portfolio records represented
REG79unique registrations represented
IDX59indexed MedInfoBase presentations
SRC0additional source-observed presentations
R+0registry-only registrations
VER0registry-verified exact registrations
PKR97current validated price records
G39generic molecules in indexed catalogue
DF12dosage-form groups
TA8therapeutic areas
How to read these counts

RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.

PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.

IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.

Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.

Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.

Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.

Data coverage

How complete is this profile?

Current price coverage95%
public portfolio presentations with a validated current price
Official-source coverage100%
products linked back to a source record
Unit-price parse coverage98%
priced packs safely normalized per unit
Comparable-market coverage93%
products with at least one like-for-like comparator
Therapeutic classification100%
products assigned to a broad therapeutic area
Visual intelligence

Downloadable company intelligence charts

Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.

Shareable intelligence

Therapeutic Portfolio Mix

Shows where the company portfolio is concentrated across broad therapeutic areas.

Therapeutic Portfolio MixFocus & Rulz Pharmaceuticals (Pvt) LtdShare of current product presentations by broad therapeutic areaMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/focus-rulz-pharmaceuticals-pvt-ltdGenerated 23 Sep 2026Anti-infectives60 · 59%Vitamins, minerals & nutrition11 · 11%CNS & mental health10 · 10%Cardiovascular7 · 7%Pain & musculoskeletal4 · 4%Respiratory & allergy4 · 4%Gastrointestinal & hepatology4 · 4%Other therapeutic areas2 · 2%Percentages are based on current product presentations in the MedInfoBase company portfolio.

Portfolio distribution, not sales or market-share data.

Shareable intelligence

Dosage Form Portfolio

Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.

Dosage Form PortfolioFocus & Rulz Pharmaceuticals (Pvt) LtdDistribution of current product presentations by normalized dosage formMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/focus-rulz-pharmaceuticals-pvt-ltdGenerated 23 Sep 2026102presentationsTablet41 · 40%Suspension17 · 17%Capsule12 · 12%Injection11 · 11%Syrup6 · 6%Cream5 · 5%Other forms10 · 10%Dosage-form wording is normalized for intelligence display; original source wording remains preserved in product records.

Counts are product presentations, not production or sales volumes.

Shareable intelligence

Equivalent Price Position

Shows whether safely comparable products are below, near or above the peer median unit price.

Equivalent Price PositionFocus & Rulz Pharmaceuticals (Pvt) LtdCurrent company products compared with like-for-like equivalent medicines using normalized unit pricesMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/focus-rulz-pharmaceuticals-pvt-ltdGenerated 23 Sep 202695comparable productsBelow peer median25 · 26%Near peer median50 · 53%Above peer median20 · 21%Company median price position-0.2%Lowest-price equivalents7Method: same generic + stated strength + dosage form + compatible unit basis; pack prices normalized per unit.

This is price-position intelligence, not sales, demand or market-share data.

Shareable intelligence

Closest Portfolio Competitors

Highlights other manufacturers with the greatest generic overlap with this company portfolio.

Closest Portfolio CompetitorsFocus & Rulz Pharmaceuticals (Pvt) LtdCompanies with the largest number of shared generic medicines in the MedInfoBase databaseMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/focus-rulz-pharmaceuticals-pvt-ltdGenerated 23 Sep 2026Nabiqasim Industries (Pvt) Ltd.,27 shared69% overlapBio-Labs(Pvt) Ltd25 shared64% overlapMediate Pharmaceutical Pvt Ltd25 shared64% overlapNovaMed Pharmaceuticals(Pvt.)Ltd25 shared64% overlapGlobal Pharmaceuticals (Pvt.) Ltd.24 shared62% overlapValor Pharmaceuticals24 shared62% overlapPortfolio overlap measures shared generics only; it is not a measure of market share, affiliation or sales competition.

Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.

Portfolio intelligence

Therapeutic areas

Broad portfolio view

High-level clinical areas represented by this company’s current MedInfoBase portfolio.

Anti-infectives60 products · 59%
Vitamins, minerals & nutrition11 products · 11%
CNS & mental health10 products · 10%
Cardiovascular7 products · 7%
Pain & musculoskeletal4 products · 4%
Respiratory & allergy4 products · 4%
Gastrointestinal & hepatology4 products · 4%
Fluids & supportive care2 products · 2%
Pharmacological detail

Drug classes

More specific view

More specific classes derived from the canonical generic and preserved curated classifications.

Third-generation cephalosporins14 products · 14%
Antimalarials13 products · 13%
Vitamins / minerals / hematinics11 products · 11%
Fluoroquinolone antibacterials10 products · 10%
Antiepileptics8 products · 8%
Macrolide antibacterials6 products · 6%
Calcium-channel blockers5 products · 5%
Antifungals4 products · 4%
Formulation footprint

Dosage forms

Tablet41 products
Suspension17 products
Capsule12 products
Injection11 products
Syrup6 products
Cream5 products
Solution4 products
Sachet2 products
Gel1 products
Infusion1 products
Ointment1 products
Pessary1 products
How MedInfoBase classifies the portfolio

MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.

Portfolio leaders

Deepest brand families

Ranked by registered presentations · not sales
#1 LectomLevetiracetam 6presentations 100 mg/mL, 1000 mg, 500 mg · Solution, Tablet #2 RuzoneCeftriaxone 6presentations 1 g, 250 mg, 500 mg · Injection #3 CiprulzCiprofloxacin 5presentations 125 mg/5 mL, 250 mg, 250 mg/5 mL, 500 mg · Suspension, Tablet #4 VfixCefixime 5presentations 100 mg/5 mL, 200 mg, 200 mg/5 mL, 400 mg · Suspension, Capsule #5 M-FerIron polymaltose complex 4presentations 100 mg, 50 mg/5 mL · Tablet, Syrup #6 ClarolidClarithromycin 3presentations 125 mg/5 mL, 250 mg, 500 mg · Suspension, Tablet
Price intelligence

Unit-price positioning vs equivalent products

Same generic + strength + form + unit basis
Below market median2526% of comparable products
Near market median50within ±5% of median
Above market median2021% of comparable products
Lowest-price equivalents7ties included
Company median price position -0.2% relative to the median unit price of like-for-like equivalent products.
Most competitively positioned examplesProducts with at least 3 market comparators
Woff 500 mgLevofloxacin · Tablet · 10x10's PKR 30.51/tablet-61.4% vs market median Neopres 5 mgAmlodipine · Tablet · 2x10's PKR 5.93/tablet-45.3% vs market median Bumo 10 mg/gSilver sulfadiazine · Cream · 250 g PKR 2.97/g-42.7% vs market median Neopres 10 mgAmlodipine · Tablet · 2x10's PKR 10.90/tablet-38.7% vs market median Cycloz 400 mgAciclovir · Tablet · 25’s PKR 41.21/tablet-30.3% vs market median
How MedInfoBase calculates price position

Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.

Competitive landscape

Portfolio overlap

Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.

Nabiqasim Industries (Pvt) Ltd.,365 products · 118 generics 27shared generics Bio-Labs(Pvt) Ltd236 products · 82 generics 25shared generics Mediate Pharmaceutical Pvt Ltd236 products · 90 generics 25shared generics NovaMed Pharmaceuticals(Pvt.)Ltd187 products · 62 generics 25shared generics Global Pharmaceuticals (Pvt.) Ltd.224 products · 80 generics 24shared generics Valor Pharmaceuticals219 products · 97 generics 24shared generics
Regulatory & price activity

Observed database signals

Indexed registration numbers79Distinct registrations among indexed, published, presentation-validated products only
Verified price observations199
Products with a verified price102
Products with multiple price observations97
Source records with multiple versions102
Latest portfolio source check22 Sep 2026
Latest effective price date17 Aug 2026
Latest source observation23 Sep 2026

These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.

Company medicine portfolio

Medicine portfolio

79 unique registration(s) · 59 indexed presentation(s)

This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.

Intelligence filter: Therapeutic areaAnti-infectives Clear intelligence filters
Reset
BrandGenericStrengthFormPackRegistrationSource-listed priceUnit pricePrice position
Arther Artemether + Lumefantrine 20 mg + 120 mg Tablet 16’s 049292 PKR 611.83 PKR 38.24/tablet Near median
Arther Artemether + Lumefantrine 40 mg + 240 mg Tablet 8’s 049306 PKR 504.75 PKR 63.09/tablet Near median
Arther Dry Artemether + Lumefantrine 15 mg + 90 mg/5 mL Dry suspension 60ml 068894 PKR 352.80 PKR 5.88/mL Near median
Arther Dry Artemether + Lumefantrine 15 mg + 90 mg/5 mL Dry suspension 30 ml 068894 PKR 176.40 PKR 5.88/mL Near median
Arther DS Dry Artemether + Lumefantrine 30 mg + 180 mg/5 mL Dry suspension 60ml 072849 PKR 588.01 PKR 9.80/mL Near median
Arther DS Dry Artemether + Lumefantrine 30 mg + 180 mg/5 mL Dry suspension 30 ml 072849 PKR 274.40 PKR 9.15/mL 7% below median
Arther Forte Artemether + Lumefantrine 80 mg + 480 mg Tablet 1x6’s 066639 PKR 630.94 PKR 105.16/tablet Near median
Arther Forte Artemether + Lumefantrine 80 mg + 480 mg Tablet 1x4’s 066639 PKR 420.63 PKR 105.16/tablet Near median
Bumo Sulphadiazine 10 mg/g Cream 50g 050917 PKR 191.20 PKR 3.82/g 45% above median
Bumo Silver sulfadiazine 10 mg/g Cream 250 g 050917 PKR 741.83 PKR 2.97/g 43% below median
Ciprulz Ciprofloxacin 250 mg Tablet 1x10’s 049297 PKR 248.55 PKR 24.86/tablet Near median
Ciprulz Ciprofloxacin 500 mg Tablet 1x10’s 049298 PKR 411.06 PKR 41.11/tablet Near median
Ciprulz Ciprofloxacin 500 mg Tablet 10x10's 049298 PKR 3,840.90 PKR 38.41/tablet 10% below median
Ciprulz Ciprofloxacin 125 mg/5 mL Dry suspension 60ml 068892 PKR 222.36 PKR 3.71/mL Near median
Ciprulz Ciprofloxacin 250 mg/5 mL Dry suspension 60ml 068893 PKR 305.92 PKR 5.10/mL Near median
Ciprulz 100ml Ciprofloxacin 200 mg IV infusion 100ml 087367 PKR 184.66 PKR 1.85/mL 19% below median
Clarolid Clarithromycin 125 mg/5 mL Dry suspension 60ml 068895 PKR 426.36 PKR 7.11/mL Near median
Clarolid Clarithromycin 250 mg Tablet 10's 083503 PKR 443.19 PKR 44.32/tablet 7% below median
Clarolid Clarithromycin 500 mg Tablet 10's 083504 PKR 738.63 PKR 73.86/tablet 12% below median
Clinda-V Vaginal Clindamycin 20 mg/g Cream 40g 049302 PKR 609.47 PKR 15.24/g 12% above median
Cloteen-V Clotrimazole 20 mg/g Cream 35g (with applicator) 049303 PKR 180.67 — No comparator
Cloteen-V Clotrimazole 500 mg Vaginal tablet 1’s 066640 PKR 135.90 PKR 135.90/tablet 6% above median
Cycloz Aciclovir 50 mg Cream 10g 012390 PKR 541.50 PKR 54.15/g No comparator
Cycloz Aciclovir 400 mg Tablet 25’s 026188 PKR 1,030.14 PKR 41.21/tablet 30% below median
Cycloz Aciclovir 800 mg Tablet 25’s 026688 PKR 1,911.94 PKR 76.48/tablet 7% above median
F-CQ Chloroquine 200 mg Tablet 50's 101880 PKR 722.57 PKR 14.45/tablet Near median
F-CQ Chloroquine 200 mg Tablet 30’s 101880 PKR 433.54 PKR 14.45/tablet Near median
Flurulz Fluconazole 150 mg Capsule 1's 049299 PKR 263.84 PKR 263.84/capsule Near median
Fociquin Chloroquine 250 mg Tablet 500's 101881 PKR 619.81 PKR 1.24/tablet 21% below median
Fociquin Chloroquine 50 mg/5 mL Syrup 60ml 101882 PKR 19.27 PKR 0.32/mL Near median
Merovite Meropenem 1 g Injection 1vial 115247 PKR 4,130.52 PKR 4,130.52/vial/unit 6% above median
Merovite Injectiom Meropenem 500 mg Injection 1vial 115246 PKR 2,209.84 PKR 2,209.84/vial/unit 6% above median
Mico Scalp Miconazole 20 mg/g Gel 20g 056794 PKR 184.75 PKR 9.24/g 10% above median
Moxirulz Moxifloxacin 400 mg Tablet 5’s 082338 PKR 877.13 PKR 175.43/tablet Near median
Ruzone Ceftriaxone 250 mg Injection 1's 054652 PKR 193.10 PKR 193.10/vial/unit Near median
Ruzone Ceftriaxone 500 mg Injection 1's 054653 PKR 325.03 PKR 325.03/vial/unit Near median
Ruzone Ceftriaxone 1 g Injection 1's 054654 PKR 613.73 PKR 613.73/vial/unit Near median
Ruzone Ceftriaxone 250 mg Injection 1's 088464 PKR 186.50 PKR 186.50/vial/unit Near median
Ruzone Ceftriaxone 500 mg Injection 1's 088465 PKR 313.92 PKR 313.92/vial/unit Near median
Ruzone Ceftriaxone 1 g Injection 1's 088466 PKR 592.76 PKR 592.76/vial/unit Near median
Sp-mal Artesunate 100 mg Tablet 1x9’scombo pack 063483 PKR 200.76 — No comparator
Tenv Tenofovir disoproxil 300 mg Tablet 3x10's 077658 PKR 6,596.23 PKR 219.87/tablet Near median
Trag Cefotaxime 250 mg Injection 1's 054655 PKR 105.47 PKR 105.47/vial/unit Near median
Trag Cefotaxime 500 mg Injection 1's 054656 PKR 158.95 PKR 158.95/vial/unit Near median
Trag Cefotaxime 1 g Injection 1's 054657 PKR 285.88 PKR 285.88/vial/unit Near median
Vfix Cefixime 400 mg Capsule 5's 049300 PKR 563.10 PKR 112.62/capsule Near median
Vfix Cefixime 100 mg/5 mL Dry suspension 30ml 049301 PKR 314.24 PKR 10.47/mL Near median
Vfix Cefixime 200 mg Capsule 5's 066641 PKR 304.68 PKR 60.94/capsule Near median
Vfix Cefixime 200 mg Capsule 10’s 066641 PKR 507.81 PKR 50.78/capsule 19% below median
Vfix Cefixime 200 mg/5 mL Dry suspension 30ml 066642 PKR 384.54 PKR 12.82/mL Near median
MedInfoBase company-intelligence methodology

This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.

Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.

Cite this record

Manufacturer record
MedInfoBase. (2026). Focus & Rulz Pharmaceuticals (Pvt) Ltd — registered product portfolio in Pakistan [Data set]. MedInfoBase. Retrieved September 23, 2026, from https://medinfobase.com/company/focus-rulz-pharmaceuticals-pvt-ltd/
Download .RIS Download .BIB EndNote, Zotero, Mendeley, RefWorks

Records change over time. Please cite the access date so readers can locate the version you used.